BN 10/24 13:23 *SHIRE SAYS ABBVIE BREAK FEE ALLOWS INVESTMENT IN FUTURE GROWTH
BN 10/24 13:21 *SHIRE: HIGH SINGLE-DIGIT 4Q SALES GROWTH FOR REPLAGAL, ELAPRASE
BN 10/24 13:19 *SHIRE SEES GROWTH RATES FOR ELAPRASE AND REPLAGAL MODERATING
BN 10/24 13:18 *SHIRE EXPECTS GENERIC COMPETITOR FOR INTUNIV IN U.S. FROM DEC.
BN 10/24 13:21 *SHIRE: HIGH SINGLE-DIGIT 4Q SALES GROWTH FOR REPLAGAL, ELAPRASE
BN 10/24 13:19 *SHIRE SEES GROWTH RATES FOR ELAPRASE AND REPLAGAL MODERATING
BN 10/24 13:18 *SHIRE EXPECTS GENERIC COMPETITOR FOR INTUNIV IN U.S. FROM DEC.
*SHIRE SEES GROWTH RATES FOR ELAPRASE AND REPLAGAL MODERATING
2014-10-24 13:20:58.565 GMT
--BENJAMIN DOW
-0- Oct/24/2014 13:20 GMT
2014-10-24 13:20:58.565 GMT
--BENJAMIN DOW
-0- Oct/24/2014 13:20 GMT